|

Zovegalisib Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Relay Therapeutics, Inc.1

Indications

  • PIK3CA Mutation1
  • Hormone Receptor Positive Tumor1
  • Metastatic Breast Cancer1
  • HER2-negative Breast Cancer1
  • Advanced Breast Cancer1

Gilbert, Arizona1 trial

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Banner MD Anderson Cancer Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.